Lipid disorders in elderly hypertensive patients

Area of Science:

• Cardiology
• Metabolic Disorders

Background:

• Lipid disorders, including dyslipidemia, are prevalent health issues in Western countries.
• Dyslipidemia is characterized by elevated total cholesterol (> 200 mg/dL), low HDL cholesterol (< 35 mg/dL), high LDL cholesterol (> 130 mg/dL), and elevated triglycerides (> 150 mg/dL).

Purpose of the Study:

• To outline the essential management strategies for patients diagnosed with dyslipidemia.
• To emphasize the integrated approach required for effective lipid disorder treatment.

Main Methods:

• Pharmacological interventions to inhibit cholesterol synthesis and absorption.
• Medications aimed at reducing triglyceride levels and increasing HDL cholesterol.
• Dietary modifications, including reduced intake of unsaturated fats and salt (< 2.5 g/day).
• Continuous monitoring and management of blood pressure (< 130/80 mmHg).

Main Results:

• Normalization of blood pressure is a mandatory component of dyslipidemia management.
• Pharmacological treatments effectively reduce LDL cholesterol and triglycerides while increasing HDL cholesterol.
• Dietary measures are essential adjuncts to pharmacologic therapy.

Conclusions:

• A comprehensive management plan integrating pharmacotherapy and lifestyle modifications is critical for controlling lipid disorders.
• Sustained treatment adherence is vital for achieving and maintaining therapeutic goals in dyslipidemia patients.